TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
PRAX

Praxis Precision Medicines Inc

Healthcare · Biotechnology

310.50$ +0.5% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement PRAX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0%
80.0% 3,545.8% 1,782.0%
-80.0% -3,445.8% -1,682.0%
10,590.2% 3,545.8% 1,782.0%
4,094.7% 1,718.6% 658.3%
14,684.8% 1,718.6% 658.3%
-14,684.8% -5,164.4% -2,340.3%
28.6%
-14,619.5% -5,037.9% -2,137.5%
-65.4% 10.8%
-14,554.1% -5,037.9% -2,137.5%
-14,656.2% -5,020.2% -2,133.3%

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?